Orbimed Advisors LLC Dbv Technologies S.A. Transaction History

Orbimed Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$5.75 - $21.85 $3.82 Million - $14.5 Million	-665,200 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.81 - $24.58 $4.28 Million - $6.26 Million	254,500 Added 61.97%	665,200 $14.9 Million
Q1 2018 May 15, 2018	SELL	$20.86 - $26.6 $3.5 Million - $4.46 Million	-167,800 Reduced 29.01%	410,700 $9.48 Million
Q4 2017 Feb 14, 2018	BUY	$20.9 - $49.36 $1.37 Million - $3.24 Million	65,600 Added 12.79%	578,500 $14.2 Million
Q3 2017 Nov 14, 2017	BUY	$39.62 - $46.17 $20.3 Million - $23.7 Million	512,900	512,900 $21.8 Million

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $573M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.